Tilg H - Search Results

1

Interferons and their role In inflammation.

Tilg H, Kaser A. Tilg H, et al. Curr Pharm Des. 1999 Oct;5(10):771-85. Curr Pharm Des. 1999. PMID: 10526087 Review.

2

Interferon-alpha and its effects on the cytokine cascade: a pro- and anti-inflammatory cytokine.

Tilg H, Peschel C. Tilg H, et al. Leuk Lymphoma. 1996 Sep;23(1-2):55-60. doi: 10.3109/10428199609054802. Leuk Lymphoma. 1996. PMID: 9021686 Review.

3

New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine.

Tilg H. Tilg H. Gastroenterology. 1997 Mar;112(3):1017-21. doi: 10.1053/gast.1997.v112.pm9041265. Gastroenterology. 1997. PMID: 9041265 Review.

4

Differential regulation of interleukin 4 and interleukin 13 production by interferon alpha.

Kaser A, Molnar C, Tilg H. Kaser A, et al. Among authors: tilg h. Cytokine. 1998 Feb;10(2):75-81. doi: 10.1006/cyto.1997.0270. Cytokine. 1998. PMID: 9512896

5

Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapy.

Vannier E, Kaser A, Atkins MB, Fantuzzi G, Dinarello CA, Mier JW, Tilg H. Vannier E, et al. Among authors: tilg h. Eur Cytokine Netw. 1999 Mar;10(1):37-42. Eur Cytokine Netw. 1999. PMID: 10210771 Free article. Clinical Trial.

6

Interferon-beta 1b augments activation-induced T-cell death in multiple sclerosis patients.

Kaser A, Deisenhammer F, Berger T, Tilg H. Kaser A, et al. Among authors: tilg h. Lancet. 1999 Apr 24;353(9162):1413-4. doi: 10.1016/S0140-6736(99)00622-4. Lancet. 1999. PMID: 10227230 No abstract available.

7

A role for IL-16 in the cross-talk between dendritic cells and T cells.

Kaser A, Dunzendorfer S, Offner FA, Ryan T, Schwabegger A, Cruikshank WW, Wiedermann CJ, Tilg H. Kaser A, et al. Among authors: tilg h. J Immunol. 1999 Sep 15;163(6):3232-8. J Immunol. 1999. PMID: 10477592

8

Plasma levels of soluble Fas during treatment of chronic hepatitis C patients with interferon alpha.

Kaser A, Vogel W, Tilg H. Kaser A, et al. Among authors: tilg h. J Hepatol. 1999 Sep;31(3):575. doi: 10.1016/s0168-8278(99)80056-7. J Hepatol. 1999. PMID: 10488723 Clinical Trial. No abstract available.

9

Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression.

Kaser A, Nagata S, Tilg H. Kaser A, et al. Among authors: tilg h. Cytokine. 1999 Oct;11(10):736-43. doi: 10.1006/cyto.1998.0484. Cytokine. 1999. PMID: 10525311

10

Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway.

Kaser A, Enrich B, Ludwiczek O, Vogel W, Tilg H. Kaser A, et al. Among authors: tilg h. Clin Exp Immunol. 1999 Oct;118(1):71-7. doi: 10.1046/j.1365-2249.1999.01020.x. Clin Exp Immunol. 1999. PMID: 10540162 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

522 results

Search Page

Filters